LIS Glossary — Clinical Lab Informatics Terms

Quick answer: A clinical LIS glossary covers the protocols (HL7 v2, FHIR R4), workflow concepts (accessioning, autoverification, reflex), QC patterns (Levey-Jennings, Westgard), compliance frameworks (CLIA, CAP, HIPAA, 21 CFR Part 11), coding standards (LOINC, CPT, ICD-10), and reporting patterns (ELR, MDM) that lab directors, LIS analysts, IT teams, and procurement encounter when evaluating laboratory information systems.

This glossary defines the terms LIMS IQ uses across solution and feature pages, plus the broader lab-informatics vocabulary that shows up in RFPs, inspections, and integration scoping. Definitions are intentionally short — one to three sentences each. Where a term has a full LIMS IQ feature or guide page, the definition links to it.

Standards and protocols

• HL7 v2 (or HL7 v2.x) — The dominant production protocol for healthcare data exchange. Carries pipe-delimited messages between EMRs, the LIS, instruments, reference labs, and public-health agencies. See the HL7 LIS integration feature page.
• FHIR (Fast Healthcare Interoperability Resources) — A modern REST + JSON healthcare data standard. FHIR R4 is the current widely-deployed release. Uses resources like Patient, ServiceRequest, Specimen, Observation, and DiagnosticReport for the same flows HL7 v2 covers. See the FHIR for clinical labs guide for resource-by-resource detail.
• ORM — HL7 v2 order message. Carries the test order from the placer (often the EMR) to the filler (the LIS).
• ORU — HL7 v2 unsolicited observation result message. Carries finalized lab results from the LIS to the EMR or downstream system.
• ADT — HL7 v2 patient admit/discharge/transfer message. Keeps patient demographics in sync between the EMR and the LIS.
• DFT — HL7 v2 detail financial transaction. Carries billing-relevant data such as test-level CPT codes from the LIS to a billing or revenue cycle system.
• MDM — HL7 v2 medical document management message. Carries PDF-style report documents — common for anatomic pathology, microbiology workups, and toxicology confirmation reports.
• MLLP — Minimal Lower-Layer Protocol. The TCP/IP framing used to wrap HL7 v2 messages for production interface delivery. Hospital interfaces typically use MLLP; ambulatory and reference-lab partners more often use SFTP or HTTPS.
• ASTM — ASTM E1394 is an older interface standard for analyzer-to-LIS connections. Many chemistry, hematology, and immunology instruments still ship with ASTM-only output; the LIS converts ASTM to the lab’s standard message envelope.

Coding standards

• LOINC — Logical Observation Identifiers Names and Codes. A universal vocabulary identifying lab tests and observations. The standard interface code for result identification. See the LOINC mapping guide for the six-axis structure and common pitfalls.
• CPT codes — Current Procedural Terminology codes maintained by the AMA. Identifies the billable procedure for a given lab test on a claim.
• ICD-10 — International Classification of Diseases, 10th revision. Identifies the diagnosis supporting medical necessity for a lab order on a claim.
• SNOMED CT — Clinical terminology covering diagnoses, findings, and clinical concepts; sometimes used alongside ICD-10 in structured reporting.
• HCPCS — Healthcare Common Procedure Coding System. The CMS code set for items and services not captured by CPT — relevant for some specialty lab billing.
• NDC — National Drug Code. Used in toxicology workflows to identify medications detected or screened against.

Compliance frameworks

• CLIA — Clinical Laboratory Improvement Amendments. The U.S. federal regulatory program under CMS for clinical labs, governed by 42 CFR Part 493. Establishes lab certification levels (waived, moderate complexity, high complexity) and the QC, proficiency testing, and personnel requirements for each.
• CAP — College of American Pathologists. Voluntary professional accreditation widely held by hospital, reference, and specialty labs. Recognized by CMS as deemed status for CLIA inspection purposes.
• HIPAA — Health Insurance Portability and Accountability Act. The U.S. federal framework for protected health information (PHI) — privacy, security, and breach notification. Applies to every lab handling patient data.
• 21 CFR Part 11 — FDA’s regulation on electronic records and electronic signatures. Applies to FDA-regulated work including clinical trials, IVDs, and pharma QC. Adds explicit electronic-signature, audit-trail, and computer-system validation expectations.
• GCP (Good Clinical Practice) — ICH guideline governing clinical trial conduct, including data integrity, electronic records, and validation expectations. Often invoked alongside 21 CFR Part 11 for clinical-trial lab work.
• GLP / GMP — Good Laboratory Practice / Good Manufacturing Practice. FDA quality systems for non-clinical research labs (GLP) and pharma/biotech manufacturing labs (GMP). Generally LIMS, not LIS, territory.
• ISO 15189 — International standard for medical laboratory quality and competence. Common outside the U.S.
• ISO 17025 — International standard for testing and calibration laboratories. Common in environmental, calibration, and forensic labs.

Lab workflow concepts

• Accessioning — The intake step where a specimen is received, identified, labeled with a unique accession number, and entered into the LIS. See accessioning LIS software.
• Aliquot — A portion of a parent specimen divided off for separate testing, storage, or shipping. Aliquots inherit the parent’s identity in chain of custody.
• Autoverification — Rule-based automated release of lab results when configured conditions are met (within reference range, QC passing, no flags, no delta-check failure). See rules-based resulting & autoverification.
• Chain of custody — The documented, tamper-evident history of every action on a specimen from collection through disposition. Essential for toxicology, forensic, and any regulated workflow. See chain of custody & audit trail.
• Critical value — A test result outside a threshold where delayed action could harm the patient. Critical values trigger documented notification with timestamps and acknowledgment per CAP expectations.
• Delta check — Comparison of a new result against the patient’s prior result for the same analyte. A failing delta check is one common reason autoverification falls out for manual review.
• Reagent lot — A specific manufactured batch of a reagent. Lot tracking lets the lab identify which patient results were produced with a recalled or out-of-spec lot.
• Reference range — The expected normal-value range for an analyte, often age- and sex-specific. The LIS evaluates each result against the configured reference range and flags abnormals.
• Reflex testing (reflex rules) — Automatic ordering of follow-on tests based on the result of an initial test (e.g., positive TSH triggers free T4). Implemented as configurable rules in the LIS.
• Specimen lineage — Parent-child traceability across aliquots, derivatives, and pooled samples. Important for molecular, biorepository, and clinical-trial work.
• STAT — A priority level marking an order as urgent. STAT compliance — the proportion of STAT orders meeting turnaround targets — is a standard lab operational KPI.
• Turnaround time (TAT) — Time elapsed between two defined events. “In-lab TAT” usually means accession-to-release; “total TAT” usually means collection-to-result-in-chart. A core operational KPI tracked in the lab analytics dashboard.

Quality control concepts

• Levey-Jennings chart — A control chart that plots successive QC measurements against the mean and standard-deviation bands. Visual indicator of analytic drift over time.
• Westgard rules — A multi-rule decision system for evaluating QC runs (1-2s, 1-3s, 2-2s, R-4s, 4-1s, 10-x). Used to decide whether to accept a run, repeat QC, or stop testing until corrective action.
• Control material — A sample with known target values used to verify analytic performance. Multi-level controls test analyte ranges across the analyzer’s clinical envelope.
• Proficiency testing (PT) — External verification where labs receive unknown samples, test them, and submit results to a comparison program. CAP, AAB, and API are common PT providers.
• Corrective action (CAPA) — Documented investigation and remediation following a quality event. Tied to QC failures, repeat-result trends, or PT misses; auditable in the LIS audit trail. See QC LIS software.

Reporting and external delivery

• ELR (Electronic Laboratory Reporting) — Structured submission of reportable lab results to a public-health agency (state, territorial, or CDC). Typically HL7 v2.5.1 ORU with state-specific code mappings. See the electronic laboratory reporting guide for the full implementation detail.
• APHL — Association of Public Health Laboratories. Publishes ELR implementation guides and ELR meta-data standards used by state health departments.
• LRN — Laboratory Response Network. The CDC’s federated network of state, federal, and partner labs that respond to biological, chemical, and radiological events.
• Result amendment — A change to a previously released result. Generates a corrected ORU and an MDM amendment record; must propagate to the EMR, the patient portal, and any downstream consumers.
• Critical-result delivery — Time-tracked notification of a critical value to an ordering clinician, with acknowledgment captured in the LIS. CAP requires documented delivery time. See the critical-value reporting workflow guide for the nine-stage process and CLIA / CAP primary-source citations.

Test type and specialty terms

• POL (Physician Office Lab) — A clinical lab embedded in a physician practice, group practice, or urgent care, often running CLIA-waived and moderate-complexity testing. See physician office lab LIS.
• DTC (Direct-to-Consumer) — Lab testing ordered by the patient rather than a clinician. Subject to state-specific regulation. See direct-to-consumer for labs.
• Reference lab — A clinical lab that performs testing on specimens received from other labs, hospitals, or providers (“send-outs”). Routing rules, billing splits, and TAT SLAs are the operational center.
• NGS (Next-Generation Sequencing) — High-throughput parallel DNA/RNA sequencing producing millions of reads per run. See NGS LIS.
• PCR (Polymerase Chain Reaction) — Amplification technique used in molecular diagnostics for pathogen detection, oncology mutation testing, and forensics. See molecular LIS.
• LC-MS/MS — Liquid chromatography tandem mass spectrometry. The confirmation standard for toxicology and many specialty quantitations. See the toxicology reflex testing guide for how the LIS reflexes a presumptive immunoassay positive into an LC-MS/MS confirmation order on the same specimen.
• Immunoassay — Detection or quantitation using antigen-antibody binding. The dominant chemistry-platform technique for hormones, drug screens, and infectious disease markers.
• FISH (Fluorescence In Situ Hybridization) — A cytogenetic technique that uses fluorescent probes to detect specific gene rearrangements, fusions, and copy-number changes on a slide. Common in oncology (for example BCR-ABL, HER2) and prenatal work. See the cytogenetics & FISH LIS guide for probe-lot tracking, scoring worksheets, and ISCN reporting.
• ISCN / karyotype — The International System for Human Cytogenomic Nomenclature, the standard for describing a specimen’s chromosome complement and abnormalities as a structured result string. Produced by karyotyping and FISH assays. See the cytogenetics LIS guide.

Billing terms

• Modifier — A two-character code appended to a CPT to refine the procedure description (e.g., -91 repeat clinical lab test, -QW CLIA-waived).
• Medical necessity — The principle that a payer covers a test only when supported by a qualifying diagnosis. Verified at order time via ICD-10 coding.
• 837 — The ANSI X12 healthcare claim transaction set. The 837P (professional) is the typical lab-billing claim format.
• EOB / ERA — Explanation of Benefits (paper) / Electronic Remittance Advice (835 EDI). Returned from the payer with claim adjudication details.
• MRO (Medical Review Officer) — Physician credentialed to interpret toxicology results for workplace and forensic programs.
• PAMA — Protecting Access to Medicare Act. Drives Medicare clinical lab fee schedule pricing via market-rate data submissions.
• Denial / RCM — Denied claim returned from a payer; revenue cycle management is the workflow for reworking and resubmitting. See revenue cycle management.

Roles and operational terms

• Lab director — The clinical or research leader responsible for the lab’s quality, regulatory standing, and reporting under CLIA, CAP, and state rules.
• Pathologist — Clinician responsible for anatomic pathology, clinical pathology, or both. Signs out cases and reviews complex result interpretation — including cytology cases after cytotechnologist screening.
• Technologist (medical lab scientist, MLS) — The bench staff who run testing, review QC, and execute the daily workflow.
• Phlebotomist — Specimen collection staff, in-clinic or mobile. See phlebotomy software for mobile draw workflow support.
• LIS analyst — The person responsible for LIS configuration, interface management, validation, and the lab’s day-to-day platform operations.
• SOP (Standard Operating Procedure) — The documented procedure for a specific lab process. Cited in audits and validation packages.

Where to go next

• Clinical LIS guide — buyer’s overview of clinical LIS systems
• Cloud LIS software guide — cloud LIS evaluation framework
• LIS vs LIMS and LIS vs EMR — comparison guides
• LIS buyer’s guide — RFP and evaluation framework
• LIS implementation timeline — onboarding sequence
• LIS validation — IQ/OQ/PQ overview
• Integrations hub — HL7, FHIR, EMR, instrument, billing, ELR, and SSO coverage

Request a demo to see how LIMS IQ implements these capabilities for your lab, or contact the team with specific RFP terminology questions.